| Date Filed | Type | Description |
| 08/24/2023 |
4
| Walker Neal (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Exercised 9,604 options to buy
@ $0.552, valued at
$5.3k
|
|
| 07/05/2023 |
4
| Walker Neal (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 21,222 options to buy
@ $8.39, valued at
$178.1k
Granted 915 options to buy
@ $8.39, valued at
$7.7k
|
|
| 03/03/2023 |
4
| Walker Neal (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Sold 29,000 shares
@ $12.3651, valued at
$358.6k
Sold 30,240 shares
@ $12.6346, valued at
$382.1k
Exercised 96,150 restricted stock units
@ $0
Exercised 18,275 restricted stock units
@ $0
Exercised 24,000 restricted stock units
@ $0
Exercised 18,254 restricted stock units
@ $0 |
|
| 02/03/2023 |
4
| Walker Neal (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Sold 25,000 shares
@ $16.747, valued at
$418.7k
Sold 1,079 shares
@ $14.5671, valued at
$15.7k
Sold 600 shares
@ $15.5533, valued at
$9.3k
Sold 3,121 shares
@ $16.8827, valued at
$52.7k
Sold 200 shares
@ $17.535, valued at
$3.5k
|
|
| 01/04/2023 |
4
| Walker Neal (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Sold 23,382 shares
@ $15.1855, valued at
$355.1k
Sold 1,618 shares
@ $16.1594, valued at
$26.1k
Sold 15,000 shares
@ $14.8895, valued at
$223.3k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2022 |
4
| Walker Neal (President and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Sold 25,000 shares
@ $15.2379, valued at
$380.9k
Sold 25,000 shares
@ $15.0439, valued at
$376.1k
Sold 20,000 shares
@ $15.1828, valued at
$303.7k
|
|
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| Walker Neal (President and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 871 shares
@ $4.59, valued at
$4k
Exercised 3,034 restricted stock units
@ $0 |
|
| 09/03/2020 |
4
| Walker Neal (President and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 23,872 shares
@ $2.33, valued at
$55.6k
Granted 83,092 restricted stock units
@ $0
Exercised 83,092 restricted stock units
@ $0 |
|
| 06/11/2020 |
4
| Walker Neal (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 26,503 options to buy
@ $5.02, valued at
$133k
Granted 1,541 options to buy
@ $5.02, valued at
$7.7k
|
|
| 06/03/2020 |
4
| Walker Neal (President and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 20,976 shares
@ $1.32, valued at
$27.7k
Exercised 73,014 restricted stock units
@ $0 |
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| Walker Neal (President and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 3,675 shares
@ $1.28, valued at
$4.7k
Exercised 10,800 restricted stock units
@ $0 |
|
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2019 |
4
| Walker Neal (President and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 782 shares
@ $1.8, valued at
$1.4k
Exercised 3,033 restricted stock units
@ $0 |
|
| 06/06/2019 |
4
| Walker Neal (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 18,951 options to buy
@ $7.06, valued at
$133.8k
Granted 1,102 options to buy
@ $7.06, valued at
$7.8k
|
|
| 03/04/2019 |
4
| Walker Neal (President and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 384,600 restricted stock units
@ $0 |
|
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2018 |
4
| Walker Neal (President and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 833 shares
@ $6.3, valued at
$5.2k
Exercised 2,925 restricted stock units
@ $0 |
|
| 12/18/2018 |
4
| Walker Neal (President and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 863 shares
@ $7.31, valued at
$6.3k
Exercised 3,033 restricted stock units
@ $0 |
|
| 06/08/2018 |
4
| Walker Neal (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 15,526 options to buy
@ $8.35, valued at
$129.6k
Granted 903 options to buy
@ $8.35, valued at
$7.5k
|
|
| 05/09/2018 |
4
| Walker Neal (President and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 3,455 shares
@ $18.1, valued at
$62.5k
Exercised 12,133 restricted stock units
@ $0 |
|
| 04/09/2018 |
4
| Walker Neal (President and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $16.75, valued at
$167.5k
|
|
| 03/20/2018 |
4
| Walker Neal (President and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Acquired 9,018 shares
@ $0 |
|
| 02/05/2018 |
4
| Walker Neal (President and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 151,200 options to buy
@ $22.09, valued at
$3.3M
Granted 43,200 restricted stock units
@ $0 |
|
| 12/21/2017 |
4
| Walker Neal (President and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 922 shares
@ $24.23, valued at
$22.3k
Paid exercise price by delivering 889 shares
@ $24.12, valued at
$21.4k
Exercised 3,033 restricted stock units
@ $0
Exercised 2,925 restricted stock units
@ $0 |
|
|